National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > 2018-2025 Recurrent Glioblastoma Multiforme Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

2018-2025 Recurrent Glioblastoma Multiforme Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

Goods_sn:ygz-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

2018-2025 Recurrent Glioblastoma Multiforme Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

Hard Copy: 3600 USD
PDF Copy (single user): 3600 USD
Enterprise wide License: 7200 USD
Pages: 128
Tables and Figures: 151
Published Date: Apr 2018
Publisher: QYR Pharma & Healthcare Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

This report studies the Recurrent Glioblastoma Multiforme Treatment market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Recurrent Glioblastoma Multiforme Treatment market by product type and application/end industries.

The global Recurrent Glioblastoma Multiforme Treatment market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Recurrent Glioblastoma Multiforme Treatment.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Recurrent Glioblastoma Multiforme Treatment in these regions, from 2013 to 2025 (forecast), covering
    United States
    North America
    Europe
    Asia-Pacific
    South America
    Middle East and Africa

The major players in global and United States market, including
    Boehringer Ingelheim GmbH
    Boston Biomedical, Inc.
    Bristol-Myers Squibb Company
    Cantex Pharmaceuticals, Inc.
    Cavion LLC
    Celldex Therapeutics, Inc.
    Coherus BioSciences, Inc.
    Cortice Biosciences, Inc.
    Eisai
    Eli Lilly and Company
    EnGeneIC Ltd
    ERC Belgium SA
    GenSpera, Inc.
    Genzyme Corporation
    GW Pharmaceuticals Plc
    ImmunoCellular Therapeutics, Ltd.
On the basis of product, the market is primarily split into
    AU-105
    Axitinib
    AXL-1717
    AZD-7451
    Others
On the basis on the end users/application, this report covers
    Hospital
    Clinic
    Others

Table of Contents

2018-2025 Recurrent Glioblastoma Multiforme Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

2 Recurrent Glioblastoma Multiforme Treatment Market Overview
    2.1 Recurrent Glioblastoma Multiforme Treatment Product Overview
    2.2 Recurrent Glioblastoma Multiforme Treatment Market Segment by Type
        2.2.1 AU-105
        2.2.2 Axitinib
        2.2.3 AXL-1717
        2.2.4 AZD-7451
        2.2.5 Others
    2.3 Global Recurrent Glioblastoma Multiforme Treatment Product Segment by Type
        2.3.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
        2.3.2 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share (%) by Type (2013-2018)
        2.3.3 Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Market Share (%) by Type (2013-2018)
        2.3.4 Global Recurrent Glioblastoma Multiforme Treatment Price (USD/Pcs) by Type (2013-2018)
    2.4 United States Recurrent Glioblastoma Multiforme Treatment Product Segment by Type
        2.4.1 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
        2.4.2 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
        2.4.3 United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
        2.4.4 United States Recurrent Glioblastoma Multiforme Treatment Price (USD/Pcs) by Type (2013-2018)

3 Recurrent Glioblastoma Multiforme Treatment Application/End Users
    3.1 Recurrent Glioblastoma Multiforme Treatment Segment by Application/End Users
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Recurrent Glioblastoma Multiforme Treatment Product Segment by Application
        3.2.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.2.2 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share (%) by Application (2013-2018)
    3.3 United States Recurrent Glioblastoma Multiforme Treatment Product Segment by Application
        3.3.1 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.3.2 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 Recurrent Glioblastoma Multiforme Treatment Market Status and Outlook by Regions
    4.1 Global Market Status and Outlook by Regions
        4.1.1 Global Recurrent Glioblastoma Multiforme Treatment Market Size and CAGR by Regions (2013, 2017 and 2025)
        4.1.2 North America
        4.1.3 Asia-Pacific
        4.1.4 Europe
        4.1.5 South America
        4.1.6 Middle East and Africa
        4.1.7 United States
    4.2 Global Recurrent Glioblastoma Multiforme Treatment Sales and Revenue by Regions
        4.2.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
        4.2.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
        4.2.3 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.4 North America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.5 Europe Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.6 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.7 South America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
        4.2.8 Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.9 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 Global Recurrent Glioblastoma Multiforme Treatment Market Competition by Players/Manufacturers
    5.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share by Players (2013-2018)
    5.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Share by Players (2013-2018)
    5.3 Global Recurrent Glioblastoma Multiforme Treatment Average Price (USD/Pcs) by Players (2013-2018)
    5.4 Global Top Players Recurrent Glioblastoma Multiforme Treatment Manufacturing Base Distribution, Sales Area, Product Types
    5.5 Recurrent Glioblastoma Multiforme Treatment Market Competitive Situation and Trends
        5.5.1 Recurrent Glioblastoma Multiforme Treatment Market Concentration Rate
        5.5.2 Global Recurrent Glioblastoma Multiforme Treatment Market Share (%) of Top 3 and Top 5 Players
        5.5.3 Mergers & Acquisitions, Expansion

6 United States Recurrent Glioblastoma Multiforme Treatment Market Competition by Players/Manufacturers
    6.1 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share by Players (2013-2018)
    6.2 United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Share by Players (2013-2018)
    6.3 United States Recurrent Glioblastoma Multiforme Treatment Average Price (USD/Pcs) by Players (2013-2018)
    6.4 United States Recurrent Glioblastoma Multiforme Treatment Market Share (%) of Top 3 and Top 5 Players


7 Recurrent Glioblastoma Multiforme Treatment Players/Manufacturers Profiles and Sales Data
    7.1 Boehringer Ingelheim GmbH
        7.1.1 Company Basic Information, Manufacturing Base and Competitors
        7.1.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.1.4 Main Business/Business Overview
    7.2 Boston Biomedical, Inc.
        7.2.1 Company Basic Information, Manufacturing Base and Competitors
        7.2.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.2.4 Main Business/Business Overview
    7.3 Bristol-Myers Squibb Company
        7.3.1 Company Basic Information, Manufacturing Base and Competitors
        7.3.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.3.4 Main Business/Business Overview
    7.4 Cantex Pharmaceuticals, Inc.
        7.4.1 Company Basic Information, Manufacturing Base and Competitors
        7.4.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.4.4 Main Business/Business Overview
    7.5 Cavion LLC
        7.5.1 Company Basic Information, Manufacturing Base and Competitors
        7.5.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.5.4 Main Business/Business Overview
    7.6 Celldex Therapeutics, Inc.
        7.6.1 Company Basic Information, Manufacturing Base and Competitors
        7.6.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.6.4 Main Business/Business Overview
    7.7 Coherus BioSciences, Inc.
        7.7.1 Company Basic Information, Manufacturing Base and Competitors
        7.7.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.7.4 Main Business/Business Overview
    7.8 Cortice Biosciences, Inc.
        7.8.1 Company Basic Information, Manufacturing Base and Competitors
        7.8.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.8.4 Main Business/Business Overview
    7.9 Eisai
        7.9.1 Company Basic Information, Manufacturing Base and Competitors
        7.9.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Eisai Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.9.4 Main Business/Business Overview
    7.10 Eli Lilly and Company
        7.10.1 Company Basic Information, Manufacturing Base and Competitors
        7.10.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.10.4 Main Business/Business Overview
    7.11 EnGeneIC Ltd
    7.12 ERC Belgium SA
    7.13 GenSpera, Inc.
    7.14 Genzyme Corporation
    7.15 GW Pharmaceuticals Plc
    7.16 ImmunoCellular Therapeutics, Ltd.

8 Recurrent Glioblastoma Multiforme Treatment Manufacturing Cost, Industrial Chain and Downstream Buyers
    8.1 Recurrent Glioblastoma Multiforme Treatment Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
    8.3 Recurrent Glioblastoma Multiforme Treatment Industrial Chain Analysis
    8.4 Downstream Buyers in United States

9 Marketing Strategy Analysis, Distributors and Market Effect Factors
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Distributors in Untied States
    9.3 Market Effect Factors Analysis
        9.3.1 Economic/Political Environmental Change
        9.3.2 Downstream Demand Change
        9.3.3 Technology Progress in Related Industry
        9.3.4 Substitutes Threat

10 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast
    10.1 Global Recurrent Glioblastoma Multiforme Treatment Sales, Revenue Forecast (2018-2025)
        10.1.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.2 United States Recurrent Glioblastoma Multiforme Treatment Market Forecast
        10.2.1 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.2.2 United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.3 Global Recurrent Glioblastoma Multiforme Treatment Forecast by Regions
        10.3.1 North America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.2 Europe Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.3 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.4 South America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.5 Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
    10.4 Recurrent Glioblastoma Multiforme Treatment Forecast by Type
        10.4.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
        10.4.2 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
    10.5 Recurrent Glioblastoma Multiforme Treatment Forecast by Application
        10.5.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Forecast by Application (2018-2025)
        10.5.2 United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Forecast by Application (2018-2025)

11 Research Findings and Conclusion


List of Tables and Figures

    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
    Figure Recurrent Glioblastoma Multiforme Treatment Product Picture
    Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) Status and Outlook (2013-2025)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) Status and Outlook (2013-2025)
    Figure Product Picture of AU-105
    Table Major Players of AU-105
    Figure Global AU-105 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of Axitinib
    Table Major Players of Axitinib
    Figure Global Axitinib Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of AXL-1717
    Table Major Players of AXL-1717
    Figure Global AXL-1717 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of AZD-7451
    Table Major Players of AZD-7451
    Figure Global AZD-7451 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of Others
    Table Major Players of Others
    Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) by Type (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Type (2013-2018)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Type (2013-2018)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Type in 2017
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Type (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Type (2013-2018)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Type (2013-2018)
    Figure 2017 Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) by Type
    Table Global Recurrent Glioblastoma Multiforme Treatment Price (USD/Pcs) by Type (2013-2018)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) by Type (2013-2018)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Type (2013-2018)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Type (2013-2018)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Type in 2017
    Table United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Type (2013-2018)
    Table United States Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Type (2013-2018)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue Share (%)by Type (2013-2018)
    Figure 2017 United States Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) by Type
    Table United States Recurrent Glioblastoma Multiforme Treatment Price (USD/Pcs) by Type (2013-2018)
    Figure Hospital Examples
    Figure Clinic Examples
    Figure Others Examples
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Comparison by Application (2013-2025)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) by Application (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Application (2013-2018)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Application (2013-2018)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Application in 2017
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Comparison by Application (2013-2025)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) by Application (2013-2018)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Application (2013-2018)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Application (2013-2018)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Application in 2017
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
    Figure North America Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Europe Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure South America Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) by Regions (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Regions (2013-2018)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Regions
    Figure 2017 United States Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) in Global Market
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Regions (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) by Regions (2013-2018)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) by Regions
    Figure 2017 United States Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) in Global Market
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table North America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Europe Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table South America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) of Key Players (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Players (2013-2018)
    Figure 2017 Global Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Players
    Figure 2018 Global Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Players
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Players (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Players (2013-2018)
    Table 2017 Global Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Players
    Table 2018 Global Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Players
    Table Global Market Recurrent Glioblastoma Multiforme Treatment Average Price (USD/Pcs) by Players (2013-2018)
    Table Global Recurrent Glioblastoma Multiforme Treatment Top Players Manufacturing Base Distribution and Sales Area
    Table Global Recurrent Glioblastoma Multiforme Treatment Top Players Product Category
    Figure Global Recurrent Glioblastoma Multiforme Treatment Market Share (%) of Top 3 Players
    Figure Global Recurrent Glioblastoma Multiforme Treatment Market Share (%) of Top 5 Players
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) by Players (2013-2018)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Players (2013-2018)
    Figure 2017 United States Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Players
    Figure 2018 United States Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Players
    Table United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Players (2013-2018)
    Table United States Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) by Players (2013-2018)
    Table 2017 United States Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Players
    Table 2018 United States Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Players
    Table United States Market Recurrent Glioblastoma Multiforme Treatment Average Price (USD/Pcs) by Players (2013-2018)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Market Share (%) of Top 3 Players
    Figure United States Recurrent Glioblastoma Multiforme Treatment Market Share (%) of Top 5 Players
    Table Boehringer Ingelheim GmbH Basic Information List
    Table Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Boston Biomedical, Inc. Basic Information List
    Table Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Bristol-Myers Squibb Company Basic Information List
    Table Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Cantex Pharmaceuticals, Inc. Basic Information List
    Table Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Cavion LLC Basic Information List
    Table Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Cavion LLC Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Celldex Therapeutics, Inc. Basic Information List
    Table Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Coherus BioSciences, Inc. Basic Information List
    Table Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Cortice Biosciences, Inc. Basic Information List
    Table Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Eisai Basic Information List
    Table Eisai Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Eisai Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Eisai Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Eisai Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table Eli Lilly and Company Basic Information List
    Table Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
    Figure Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (%)(2013-2018)
    Figure Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (%)(2013-2018)
    Table EnGeneIC Ltd Basic Information List
    Table ERC Belgium SA Basic Information List
    Table GenSpera, Inc. Basic Information List
    Table Genzyme Corporation Basic Information List
    Table GW Pharmaceuticals Plc Basic Information List
    Table ImmunoCellular Therapeutics, Ltd. Basic Information List
    Table Sales Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Recurrent Glioblastoma Multiforme Treatment
    Figure Recurrent Glioblastoma Multiforme Treatment Industrial Chain Analysis
    Table Major Buyers of Recurrent Glioblastoma Multiforme Treatment
    Table Distributors/Traders List
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Recurrent Glioblastoma Multiforme TreatmentRecurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Forecast by Regions (2018-2025)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) Forecast by Regions (2018-2025)
    Figure North America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure North America Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure South America Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure South America Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (Million USD) Forecast by Type (2018-2025)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) Forecast by Type (2018-2025)
    Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) Forecast by Type (2018-2025)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (Million USD) Forecast by Type (2018-2025)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) Forecast by Type (2018-2025)
    Table United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) Forecast by Type (2018-2025)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue Market Share (%) Forecast by Type (2018-2025)
    Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Forecast by Application (2018-2025)
    Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Forecast by Application (2018-2025)
    Table United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Forecast by Application (2018-2025)
    Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Forecast by Application (2018-2025)

Request sample If you need any reports sample, just let us know.